Ad
ANTX Short Information AN2 Therapeutics Inc.
home / stock / antx / antx short
Short Information | AN2 Therapeutics Inc. (NASDAQ:ANTX)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 684,334 |
| Total Actual Volume | 3,246,350 |
| Short Trends | |
|---|---|
| Cover Days | 19 |
| Short Days | 0 |
| No Change Days | 1 |
| Averages | |
|---|---|
| Average Short Volume | 34,217 |
| Average Short Percentage | 20.70% |
Is there a ANTX Short Squeeze or Breakout about to happen?
See the ANTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
ANTX Twenty Trading Day's Volume to Short Volume Chart
ANTX Twenty Trading Day Price Chart
ANTX Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-14-2025 | $1.27 | $1.22 | $1.2799 | $1.22 | 83,490 | 21,838 | 26.16% |
| 01-13-2025 | $1.24 | $1.26 | $1.2752 | $1.23 | 170,888 | 73,046 | 42.74% |
| 01-10-2025 | $1.29 | $1.25 | $1.29 | $1.241 | 179,457 | 23,652 | 13.18% |
| 01-08-2025 | $1.34 | $1.3 | $1.37 | $1.2909 | 81,995 | 15,711 | 19.16% |
| 01-07-2025 | $1.39 | $1.35 | $1.4 | $1.35 | 63,646 | 9,589 | 15.07% |
| 01-06-2025 | $1.44 | $1.38 | $1.44 | $1.38 | 95,617 | 13,086 | 13.69% |
| 01-03-2025 | $1.34 | $1.42 | $1.44 | $1.34 | 192,725 | 22,945 | 11.91% |
| 01-02-2025 | $1.39 | $1.39 | $1.44 | $1.36 | 182,674 | 30,685 | 16.8% |
| 12-31-2024 | $1.4 | $1.38 | $1.4191 | $1.32 | 159,467 | 54,625 | 34.25% |
| 12-30-2024 | $1.42 | $1.41 | $1.43 | $1.4 | 68,828 | 10,292 | 14.95% |
| 12-27-2024 | $1.39 | $1.44 | $1.45 | $1.39 | 154,709 | 23,586 | 15.25% |
| 12-26-2024 | $1.34 | $1.38 | $1.41 | $1.34 | 100,280 | 21,219 | 21.16% |
| 12-24-2024 | $1.42 | $1.36 | $1.42 | $1.34 | 122,288 | 33,199 | 27.15% |
| 12-23-2024 | $1.27 | $1.4 | $1.43 | $1.26 | 512,625 | 137,866 | 26.89% |
| 12-20-2024 | $1.25 | $1.26 | $1.28 | $1.235 | 113,249 | 13,425 | 11.85% |
| 12-19-2024 | $1.31 | $1.27 | $1.315 | $1.23 | 228,541 | 40,150 | 17.57% |
| 12-18-2024 | $1.34 | $1.31 | $1.37 | $1.31 | 133,216 | 33,934 | 25.47% |
| 12-17-2024 | $1.34 | $1.34 | $1.37 | $1.32 | 151,961 | 44,285 | 29.14% |
| 12-16-2024 | $1.46 | $1.35 | $1.46 | $1.33 | 294,323 | 25,291 | 8.59% |
| 12-13-2024 | $1.48 | $1.43 | $1.48 | $1.43 | 156,371 | 35,910 | 22.96% |
News, Short Squeeze, Breakout and More Instantly...
AN2 Therapeutics Inc. Company Name:
ANTX Stock Symbol:
NASDAQ Market:
AN2 Therapeutics Inc. Website:
Ad
-
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that company management will participate in two upcoming investor conferences in December. Deta...
-
Aspira Women's Health Inc. (AWH) is expected to report $-0.28 for Q3 2024 Cabaletta Bio Inc. (CABA) is expected to report $-0.59 for Q3 2024 AgriFORCE Growing Systems Ltd. (AGRI) is expected to report for Q3 2024 Elite Pharmaceuticals, Inc. (ELTP) is expected to report for Q2 2025 ...
-
Epetraborole-treated patients demonstrated clinical improvements in QOL-B and a post-hoc analysis of MACrO 2 with nominal statistical significance when evaluated as continuous measures First drug candidate with statistically favorable patient reported outcome (PRO)-based improveme...